help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ingram, R. T.
Right arrow Articles by Nicoll, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ingram, R. T.
Right arrow Articles by Nicoll, C. S.

Endocrinology, Vol 130, 3085-3091, Copyright © 1992 by Endocrine Society


ARTICLES

Binding of intact and cleaved human growth hormone to hepatic receptors and plasma binding proteins

RT Ingram, N Afshari and CS Nicoll
Department of Integrative Biology, University of California, Berkeley 94720.

The binding of intact (i) and cleaved (c) 125I-labeled human GH to the hepatic GH-binding sites and to the plasma GH-binding protein (GH-BP) of rabbits was compared. The c-hGH label was prepared by incubation of the iodinated hormone with the plasmalemal fraction of pregnant rat liver. Unlabeled c-hGH was prepared in milligram quantities by digestion with plasmin. The c-hGH label revealed both high and low affinity binding sites on the rabbit liver membranes when it was displaced by unlabeled c-hGH. Cleavage of the hGH label caused a substantial decrease in its affinity for the low affinity site. When i- hGH was used to displace either i-hGH or c-hGH tracers, it failed to discriminate between the two classes of binding sites, as it had equally high affinity for both. The c-hGH had a substantilly lower affinity for the plasma GH-BP than did the i-hGH. This difference is consistent with the c-hGH having an increased bioactivity, but not with its reported slow clearance rate. If cleavage of GH occurs at its sites of action, the lowered affinity for the plasma GH-BP, with retention of high affinity for the high affinity site, could increase its potency relative to that of the i-hGH.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society